,43,44 Recommendations should include prepregnancy dyslipidemia optimization, particularly in women with severe dyslipidemia such as FH or elevated Lp(a), and should incorporate recent National Lipid Association guidelines for managing lipid levels during and after pregnancy.27 This evidence concerns the gene LPA and metabolic syndrome.